drugset / Trial / NCT00034736

A Study to Compare the Efficacy and Safety of Levofloxacin in the Treatment of Children With Community-acquired Pneumonia in the Hospital or Outpatient Setting

NCT00034736

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and efficacy of levofloxacin in the treatment of children with community acquired pneumonia.

Timeline

Start
2002-08
Primary completion
Completion
2004-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule 10 mg/kg Intravenous

Indications